Quickly
Socially
Trending
Crypto
SII
Mpox Vaccine in India: Adar Poonawalla-Led Serum Institute of India Working on Developing Indigenous Anti-Mpox Vaccine, Says Will Share Positive News Within a Year
Malaria Vaccine R21/Matrix-M, Developed by Oxford University and Serum Institute of India, Recommended by WHO for Use, Adar Poonawalla Says 'Huge Milestone on Journey to Combat Life-Threatening Disease'
DCGI Approves Market Authorisation for SII’s COVID-19 Vaccine ‘Covovax’ As Heterologous Booster Dose
COVID-19 Spike in China News Concerning, India Need Not to Panic Given Excellent Vaccination Coverage: Adar Poonawalla
Covishield Vaccine Death Case: Bombay High Court Issues Notices to Centre, Bill Gates, Serum Institute of India
COVID-19 Vaccine Update: Serum Institute of India Will Try To Launch Omicron-Specific Vaccine After Six Months, Says Adar Poonawalla
Adar Poonawalla Suggests Elon Musk to Manufacture Tesla in India, Says ‘Best Investment You’ll Ever Make’
COVID-19 Vaccine Price in India: Covishield's Price Reduced from Rs 600 to Rs 225 Per Dose at Private Hospitals
Covishield Booster Dose Price in India: End Users Will Have To Pay Rs 600, at Discounted Price in Hospitals, Says SII
COVID-19 Vaccine: DGCI Gives Nod to SII’s Proposal To Manufacture Vaccine Against Omicron for Test, Analysis
COVID-19 Vaccine Update: Covovax, Vaccine Produced By Serum Institute of India Under License From Novavax, Gets Emergency Use Approval From WHO
Covovax, COVID-19 Vaccine Produced By Serum Institute of India Under Licence From Novavax, Gets WHO Approval For Emergency Use
Google Trends
